Intrinsiqs

Is Pacira BioSciences, Inc. overvalued?

Pacira BioSciences, Inc. (PCRX) looks undervalued — trading about 322% below its fair value.

Undervalued
Current price $23.00 Fair value $97.02
Price
$23.00
Fair value
$97.02
Current P/E
8.8
Normal P/E
37.2
Market cap
$904.7M
Dividend yield
0.0%
Return on equity
2.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PCRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.